Coalition For The Advancement Of Medical Research Transfers Mission And Assets To Alliance For Regenerative Medicine

WASHINGTON, May 21, 2013 /PRNewswire/ –The Coalition for the Advancement of Medical Research (CAMR) announced today it is transferring its mission and its assets to the Alliance for Regenerative Medicine (ARM). “Human embryonic stem cell research has grown and evolved to a point where it’s time for CAMR to hand off its mission to an organization that can advance policy initiatives to support where the science is now, and where it is headed,” said CAMR president Amy Comstock Rick, J.D Continue reading

Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy

CLEARWATER, Fla., May 20, 2013 /PRNewswire/ — Sports Medicine is always at the forefront of innovative medical technology. Athletes are constantly striving to improve. Records are broken as humans run faster, jump higher, and strive for higher levels of performance Continue reading

Exploring the Mind’s Eye: the Regenerative Potentials of Stem Cell Therapy – Video




Exploring the Mind's Eye: the Regenerative Potentials of Stem Cell Therapy This is done with the purpose of informing you guys about the regenerative potential of stem cell therapy on the eye, By: fergus chan Continue reading

Gene Therapy Used in Dogs to Treat Type 1 Diabetes

ALEXANDRIA, VA–(Marketwired – Apr 23, 2013) – In a major advance in the use of gene therapy for treating type 1 diabetes, researchers have shown that this approach can provide beneficial therapeutic effects in dogs for up to four years, without causing hypoglycemia, according to a study published in the May issue of the journal Diabetes. Researchers from the Universitat Autonoma de Barcelona, led by Dr. Continue reading

Featured Speaker: Jeff Jonas, Shire Regenerative Medicine – Video




Featured Speaker: Jeff Jonas, Shire Regenerative Medicine Jeff Jonas, M.D., President, Shire Regenerative Medicine Dr. Jonas joined Shire in July 2008 and has served as President of Shire's Regenerative Medicine bus… By: AllianceRegenMed Continue reading

Sernova and Centre for Commercialization of Regenerative Medicine Partner to Treat Chronic Diseases

TORONTO, ONTARIO and LONDON, ONTARIO–(Marketwire – Feb 28, 2013) – The Centre for Commercialization of Regenerative Medicine (CCRM) is pleased to announce the addition of Sernova Corp. (“Sernova” or the “Company”) (TSX VENTURE:SVA) to its member-based industry consortium. Continue reading

Research and Markets: Regenerative medicine and Stem cells Partnering Terms and Agreements

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/tb9cmt/regenerative) has announced the addition of the “Regenerative medicine and Stem cells Partnering Terms and Agreements” report to their offering. Continue reading

OTT Breakfast Club Winter 2012: Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine – Video




OTT Breakfast Club Winter 2012: Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine Techid: 12022 By: EmoryUniversity Continue reading

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Interview conducted by April Cashin-Garbutt, BA Hons (Cantab) Regenerative medicine is a new, exciting field that is based upon the belief that the human body has the inherent power to heal itself, but in some instances it just needs a little help. The field is based upon the application of tissue engineering, stem cell therapy, medical devices, and other biologic therapies to repair and regenerate damaged or diseased tissues and organs. DSM entered the medical field more than a decade ago, starting with R&D efforts to develop medical application based on Dyneema, which led to Dyneema Purity fiber, the most sought after high strength material for use in orthopedic sutures Continue reading

Dr. Farshchian: The Center for regenerative medicine introduces Genorthix system

“The Center for regenerative medicine introduces Genorthix system,” according to Roman Garcia PT. (PRWEB) December 25, 2012 “The Genorthix system combines the fractal geometric re-constitutive effect of ultra-sound energy with the re-hydrating and pain reliever properties contained in the Genorthix Penetrating Pain Reliever cream Continue reading

Donna Skerrett of Mesoblast on adult stem cell therapies – at Stem Cells USA




Donna Skerrett of Mesoblast on adult stem cell therapies – at Stem Cells USA RM Congress 2012 Donna Skerrett, Chief Medical Officer of Mesoblast, presented a case study on Mesoblast and their adult stem cell therapy at the Stem Cells USA Regenerative Medicine Congress 2012. The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively Continue reading

First Regen Med Investor Day Takes Place April 17, 2013 in New York City

WASHINGTON, Dec. 19, 2012 /PRNewswire/ –The Alliance for Regenerative Medicine (ARM) today announced its first Regen Med Investor Day will take place on April 17, 2013. Co-hosted by leading financial firms Burrill & Company, Piper Jaffray and Maxim Group, this one-day meeting will provide institutional, strategic and venture investors’ unique insight into the investment hypothesis for regenerative medicine-based therapeutics and tools Continue reading

California Stem Cell Agency Awards $12 Million in Grants to UCSF Physician Scientists

The California Institute for Regenerative Medicine has awarded $12 million in stem cell research grants to fund four projects at UCSF, part of a total $36 million in new awards to young researchers announced by the state agency. Continue reading

Research and Markets: Regenerative Medicine – Global Strategic Business Report

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/qjdj35/regenerative) has announced the addition of the “Regenerative Medicine – Global Strategic Business Report” report to their offering. This report analyzes the worldwide markets for Regenerative Medicine in US$ million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World Continue reading

Hemorrhage in the Knee is Now Being Treated with Regenerative Medicine at the Center for Regenerative Medicine

“Hemorrhage in the knee is now being treated with regenerative medicine at the Center for Regenerative Medicine,” according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine. Continue reading